- Home
- DOMH
as 12-20-2024 4:00pm EST
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
| Founded: | 1967 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 12.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 12.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.81 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.24 - $3.20 | Next Earning Date: | 11-08-2024 |
| Revenue: | $12,589,000 | Revenue Growth: | 1117.50% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Dominari Holdings Inc. News
DOMH Breaking Stock News: Dive into DOMH Ticker-Specific Updates for Smart Investing
ACCESSWIRE
a month ago
Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team
Simply Wall St.
a month ago
Dominari Holdings Third Quarter 2024 Earnings: US$0.67 loss per share (vs US$0.66 loss in 3Q 2023)
ACCESSWIRE
3 months ago
Dominari Securities LLC Announces Appointment of Capital Markets Veteran James Hopkins as Managing Director Head of Capital Markets
ACCESSWIRE
4 months ago
Dominari Securities LLC Receives Milestone Approval as a Nasdaq Limited Underwriting Member
Simply Wall St.
4 months ago
Several Insiders Invested In Dominari Holdings Flagging Positive News
ACCESSWIRE
8 months ago
Dominari Securities LLC Continues Expansion of Its Capital Market Group with Senior Hires
Insider Monkey
8 months ago
10 Micro-Cap Healthcare Stocks Insiders Are Buying
PR Newswire
9 months ago
Dominari Securities Appoints 30 Year Financial Industry Expert to Manage Operations and Compliance
Compare DOMH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DOMH Dominari Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.